Abstract
Purpose
To describe the clinical and fertility outcomes after uterine artery embolization (UAE) for symptomatic uterine arteriovenous malformations (AVMs).
Materials and Methods
This single-center retrospective study included 33 patients with uterine AVMs who underwent UAE at our institution between May 2013 and May 2021. The inclusion criteria were diagnostic features of uterine AVM as detection of the nidus and early venous drainage on angiography. The exclusion criteria were high levels of beta-human chorionic gonadotropin indicative of gestational trophoblastic neoplasia. Polyvinyl alcohol (PVA) with a diameter of 500–700 µm (with or without Gelfoam/Glue) was used in 32 procedures and, Glue (with lipiodol) was used in one. The patients were followed up for 31 months (range, 6–90 months). Angiograms, medical records, and phone interviews were used to describe the technical and clinical success, complications, and pregnancy outcomes.
Results
Thirty-three patients with a mean age of 31.2 ± 5.4 years (range, 21–42 years) were included in this case series. Technical success was reported in all patients (100%). Bleeding control was also achieved in 32 (96%) patients. Pelvic and puncture site pain and groin hematoma were reported as minor complications (grade 1 according to CIRSE classification). Six pregnancies (33%) occurred after uterine artery embolization. Four women had full-term pregnancies without complications and delivered healthy newborns. Another two women were in the second trimester of pregnancy with a favorable fetal condition. No post-embolization miscarriage was reported.
Conclusion
The UAE is safe and effective in controlling vaginal bleeding caused by uterine AVMs, allowing successful future pregnancies.
Similar content being viewed by others
References
Polat PN, et al. Color Doppler US in the evaluation of uterine vascular abnormalities. Radiographics. 2002;22(1):47–53.
Chen L-K, et al. Successful transarterial embolization of uterine arteriovenous malformation: report of three cases. Iran J Radiol. 2016. https://doi.org/10.5812/iranjradiol.15358.
Zhu Y-P, et al. Clinical characteristic and management of acquired uterine arteriovenous malformation. Chin Med J. 2018;131(20):2489.
Sellers F, et al. Uterine arteriovenous malformation. Case Rep. 2013. https://doi.org/10.1136/bcr-2012-008443.
Kim T-H, Lee H-H. Presenting features of women with uterine arteriovenous malformations. Fertil Steril. 2010;94(6):2330.e7-2330.e10.
Katimada Annaiah T, Kodakkattil Sreenivasan S. Uterine arteriovenous malformations: clinical implications. Obstet Gynaecol. 2015;17(4):243–50.
Brown JV, et al. Contemporary diagnosis and management of a uterine arteriovenous malformation. Obstet Gynecol. 2008;112(2):467–70.
Soeda S, et al. Uterine artery embolization for uterine arteriovenous malformation is associated with placental abnormalities in the subsequent pregnancy: two cases report. Fukushima J Med Sci. 2014. https://doi.org/10.5387/fms.2013-13.
Chen Y, et al. Embolization of uterine arteriovenous malformation. Iran J Reprod Med. 2013;11(2):159.
Filippiadis D, et al. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40(8):1141–6.
Molvi SN, et al. Transcatheter embolization of uterine arteriovenous malformation: report of 2 cases and review of literature. J Minim Invasive Gynecol. 2011;18(6):812–9.
Geerinckx I, Willemsen W, Hanselaar T. A syndromal and an isolated form of uterine arteriovenous malformations: two case-reports. Eur J Obstet Gynecol Reprod Biol. 2001;100(1):87–91.
Beller U, et al. Congenital arteriovenous malformation of the female pelvis: a gynecologic perspective. Am J Obstet Gynecol. 1988;159(5):1153–60.
Huang MW, et al. Uterine arteriovenous malformations: gray-scale and Doppler US features with MR imaging correlation. Radiology. 1998;206(1):115–23.
Gulati MS, et al. Uterine arteriovenous malformations: the role of intravenous ‘dual-phase’CT angiography. Clin Imag. 2000;24(1):10–4.
Camacho A, et al. Uterine artery embolization with Gelfoam for acquired symptomatic uterine arteriovenous shunting. J Vasc Interv Radiol. 2019;30(11):1750–8.
Peitsidis P, et al. Uterine arteriovenous malformations induced after diagnostic curettage: a systematic review. Arch Gynecol Obstet. 2011;284(5):1137–51.
Elia G, Counsell C, Singer SJ. Uterine artery malformation as a hidden cause of severe uterine bleeding. A case report. J Reprod Med. 2001;46(4):398–400.
Renu A et al, Arteriovenous malformations of the uterus. The New Zealand Medical Journal (Online), 2004. 117(1206).
Picel AC, Koo SJ, Roberts AC. Transcatheter arterial embolization with n-butyl cyanoacrylate for the treatment of acquired uterine vascular malformations. Cardiovasc Intervent Radiol. 2016;39(8):1170–6.
Stiepel HR III, Burke CT, Stewart JK. Embolization of uterine arteriovenous malformation causing postpartum hemorrhage using n-butyl cyanoacrylate: a case report. Radiol Case Rep. 2021;16(5):1188–90.
Firouznia K, et al. Uterine artery embolization in 101 cases of uterine fibroids: do size, location, and number of fibroids affect therapeutic success and complications? Cardiovasc Intervent Radiol. 2008;31(3):521–6.
Berkane N, Moutafoff-Borie C. Impact of previous uterine artery embolization on fertility. Curr Opin Obstet Gynecol. 2010;22(3):242–7.
Imankulova B, et al. Repeated pulmonary embolism with cardiac arrest after uterine artery embolization for uterine arteriovenous malformation: a case report and literature review. Taiwan J Obstet Gynecol. 2018;57(6):890–3.
Ho C-Y, et al. Fertility outcomes following pelvic embolization in women with acquired uterine arteriovenous malformation. Taiwan J Obstet Gynecol. 2017;56(6):831–5.
Vilos AG, et al. Uterine artery embolization for uterine arteriovenous malformation in five women desiring fertility: pregnancy outcomes. Hum Reprod. 2015;30(7):1599–605.
Funding
This study was not supported by any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Consent for publication
Consent for publication was obtained for every individual person’s data included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ghanaati, H., Firouznia, K., Moradi, B. et al. Fertility Outcomes After Uterine Artery Embolization for Symptomatic Uterine Arteriovenous Malformations: A Single-Center Retrospective Study in 33 Women. Cardiovasc Intervent Radiol 45, 983–991 (2022). https://doi.org/10.1007/s00270-022-03105-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-022-03105-2